• Science News
    • Cancer Stem Cell News
    • Cell Therapy News
    • Dermal Cell News
    • Endothelial Cell News
    • ESC & iPSC News
    • Extracellular Matrix News
    • Hematopoiesis News
    • Hepatic Cell News
    • Human Immunology News
    • Immune Regulation News
    • Immunology of Infectious Disease News
    • Intestinal Cell News
    • Neural Cell News
    • Organoid News
    • Pancreatic Cell News
    • Prostate Cell News
    • Pulmonary Cell News
    • Umbilical & Placental Cell News
  • Science Jobs
  • Science Events
  • Subscribe
  • About Us
  • Contact Us
  • Privacy Policy
  • Archives
  • Submit
  • Brought to you by
  • STEMCELL
Search
Logo
  • Science News
    • Cancer Stem Cell News
    • Cell Therapy News
    • Dermal Cell News
    • Endothelial Cell News
    • ESC & iPSC News
    • Extracellular Matrix News
    • Hematopoiesis News
    • Hepatic Cell News
    • Human Immunology News
    • Immune Regulation News
    • Immunology of Infectious Disease News
    • Intestinal Cell News
    • Mammary Cell News
    • Mesenchymal Cell News
    • Muscle Cell News
    • Neural Cell News
    • Organoid News
    • Pancreatic Cell News
    • Prostate Cell News
    • Pulmonary Cell News
  • Science Jobs
  • Science Events
Subscribe
e.g. organoids
  • Science News
    • Cancer Stem Cell News
    • Cell Therapy News
    • Dermal Cell News
    • Endothelial Cell News
    • ESC & iPSC News
    • Extracellular Matrix News
    • Hematopoiesis News
    • Hepatic Cell News
    • Human Immunology News
    • Immune Regulation News
    • Immunology of Infectious Disease News
    • Intestinal Cell News
    • Mammary Cell News
    • Mesenchymal Cell News
    • Muscle Cell News
    • Neural Cell News
    • Organoid News
    • Pancreatic Cell News
    • Prostate Cell News
    • Pulmonary Cell News
  • Science Jobs
  • Science Events
Subscribe
Home Newsletters Cancer Stem Cell News Risk of Recurrence and Cancer Stem Cell Marker CD133 Expression Vary in...
  • Newsletters
  • Cancer Stem Cell News

Risk of Recurrence and Cancer Stem Cell Marker CD133 Expression Vary in Males Versus Females with Papillary Thyroid Cancer

By
Jamie Kang
-
April 23, 2025
0
542
Scientists defined the association between CD133 expression in papillary thyroid cancer and recurrence-free survival
[Annals of Surgical Oncology]
Full Article
  • TAGS
  • Publication
Twitter
Linkedin
Facebook
    Jamie Kang
    Brought to you by

    • About Us
    • Archives
    • Contact Us
    • Privacy Policy
    • Cookie Preferences
    • Submit
    • Subscribe
    Exit mobile version